FDA NDC Directory · JSON-LD · Markdown

QUININE SULFATE

NDC 50742-238 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerIngenus Pharmaceuticals, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA204372
Dosage form / routeCAPSULE · ORAL
Active ingredientsQUININE SULFATE (324 mg/1)
Marketing started20171211
Package count1

External sources

Source: openFDA. Public-domain (CC0).